Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis.

Lee HY, Chae KO, Lee CH, Choi SM, Lee J, Park YS, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ.

PLoS One. 2014 Aug 8;9(8):e103768. doi: 10.1371/journal.pone.0103768. eCollection 2014.

2.

New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.

Ritchie SR, Harrison AC, Vaughan RH, Calder L, Morris AJ.

Eur Respir J. 2007 Sep;30(3):501-7. Epub 2007 May 30.

3.

Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.

Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1344-8. doi: 10.5588/ijtld.12.0113.

PMID:
23107634
4.

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.

Ann Intern Med. 2006 May 2;144(9):650-9.

PMID:
16670134
5.

Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Shu CC, Wang JT, Lee CH, Wang JY, Lee LN, Yu CJ.

BMC Infect Dis. 2010 Mar 6;10:48. doi: 10.1186/1471-2334-10-48.

6.

Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.

Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC.

Chest. 2013 Jun;143(6):1725-32. doi: 10.1378/chest.12-2051.

PMID:
23288018
7.

Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.

Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.

J Assoc Physicians India. 2012 Aug;60:22-6.

PMID:
23405517
9.
10.

Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment.

Chang CY, Hong JY, Yuan MK, Chang SJ, Lee YM, Chang SC, Hsu LC, Cheng SL.

Drug Des Devel Ther. 2013;7:53-8. doi: 10.2147/DDDT.S39247. Epub 2013 Jan 31.

11.

Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

George PM, Mehta M, Dhariwal J, Singanayagam A, Raphael CE, Salmasi M, Connell DW, Molyneaux P, Wickremasinghe M, Jepson A, Kon OM.

Respir Med. 2011 Nov;105(11):1726-31. doi: 10.1016/j.rmed.2011.07.014. Epub 2011 Aug 15.

12.

Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.

Kang HK, Jeong BH, Lee H, Park HY, Jeon K, Huh HJ, Ki CS, Lee NY, Koh WJ.

Medicine (Baltimore). 2016 Aug;95(31):e4540. doi: 10.1097/MD.0000000000004540.

13.

Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.

Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.

Int J Tuberc Lung Dis. 2014 May;18(5):564-70. doi: 10.5588/ijtld.13.0602.

PMID:
24903794
14.
15.

Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis.

Caetano Mota P, Carvalho A, Valente I, Braga R, Duarte R.

Rev Port Pneumol. 2012 Mar-Apr;18(2):72-9. doi: 10.1016/j.rppneu.2011.12.005. Epub 2012 Jan 25. English, Portuguese.

16.

The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses.

Tamura A, Shimada M, Matsui Y, Kawashima M, Suzuki J, Ariga H, Ohshima N, Masuda K, Matsui H, Nagai H, Nagayama N, Toyota E, Akagawa S, Hebisawa A.

Intern Med. 2010;49(2):95-102. Epub 2010 Jan 15.

17.

Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.

Kibiki GS, Mulder B, van der Ven AJ, Sam N, Boeree MJ, van der Zanden A, Dolmans WM.

Trop Med Int Health. 2007 Oct;12(10):1210-7.

18.

Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.

Scherer LC, Sperhacke RD, Ruffino-Netto A, Rossetti ML, Vater C, Klatser P, Kritski AL.

BMC Infect Dis. 2009 Dec 31;9:216. doi: 10.1186/1471-2334-9-216.

20.

Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum.

Mdivani N, Li H, Akhalaia M, Gegia M, Goginashvili L, Kernodle DS, Khechinashvili G, Tang YW.

Clin Chem. 2009 Sep;55(9):1694-700. doi: 10.1373/clinchem.2009.124396. Epub 2009 Jul 2.

Supplemental Content

Support Center